These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29322261)

  • 1. The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine.
    Martelletti P
    J Headache Pain; 2018 Jan; 19(1):2. PubMed ID: 29322261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
    Negro A; Curto M; Lionetto L; Martelletti P
    J Headache Pain; 2015; 17():1. PubMed ID: 26792662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic migraine: current concepts and ongoing treatments.
    Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulse control disorders in chronic migraine with medication overuse after onabotulinumtoxinA: A single-center prospective cohort study.
    d'Onofrio F; de Falco A; Costanzo A; Spitaleri D; Casucci G; Raimo S
    J Clin Neurosci; 2020 Oct; 80():152-155. PubMed ID: 33099338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role.
    Grazzi L; Montisano DA; Rizzoli P; Guastafierro E; Marcassoli A; Fornari A; Raggi A
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
    Takeshima T
    Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study.
    Mose LS; Pedersen SS; Debrabant B; Jensen RH; Gram B
    J Headache Pain; 2018 May; 19(1):39. PubMed ID: 29802536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From migraine to chronic daily headache: the biological basis of headache transformation.
    Meng ID; Cao L
    Headache; 2007 Sep; 47(8):1251-8. PubMed ID: 17883547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
    Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
    Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin A in chronic refractory migraine: premarketing experience].
    Álvaro-González LC; Fernández-García JM; Aranzábal-Alustiza I; Castillo-Calvo B; Iriondo-Etxenagusia I; Rodríguez-Antigüedad A
    Rev Neurol; 2012 Oct; 55(7):385-91. PubMed ID: 23011856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.
    Zhang N; Woldeamanuel YW
    Headache; 2021 Sep; 61(8):1234-1244. PubMed ID: 34370866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
    J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic and Refractory Migraine: How to Diagnose and Treat].
    Parreira E; Luzeiro I; Pereira Monteiro JM
    Acta Med Port; 2020 Nov; 33(11):753-760. PubMed ID: 33160424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-making deficit in chronic migraine patients with medication overuse.
    Biagianti B; Grazzi L; Gambini O; Usai S; Muffatti R; Scarone S; Bussone G
    Neurol Sci; 2012 May; 33 Suppl 1():S151-5. PubMed ID: 22644192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication overuse and chronic migraine: a critical review according to clinical pharmacology.
    Ferrari A; Baraldi C; Sternieri E
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1127-44. PubMed ID: 26027878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic migraine treatment: from OnabotulinumtoxinA onwards.
    Negro A; Curto M; Lionetto L; Giamberardino MA; Martelletti P
    Expert Rev Neurother; 2016 Oct; 16(10):1217-27. PubMed ID: 27310178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC3 role in medication consumption in medication overuse headache patients: a pilot study.
    Pisanu C; Caproni S; Congiu D; Cupini LM; Squassina A; Patrinos GP; Corbelli I; Calabresi P; Del Zompo M; Sarchielli P
    Hum Genomics; 2015 Nov; 9():30. PubMed ID: 26542778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
    Zeeberg P; Olesen J; Jensen R
    Cephalalgia; 2009 Feb; 29(2):214-20. PubMed ID: 18823364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of chronic daily headache in migraine patients: medication overuse headache and chronic migraine. French guidelines (French Headache Society, French Private Neurologists Association, French Pain Society)].
    Lantéri-Minet M; Demarquay G; Alchaar H; Bonnin J; Cornet P; Douay X; Dousset V; Géraud G; Guillouf V; Navez M; Radat F; Radenne S; Revol A; Valade D; Donnet A
    Rev Neurol (Paris); 2014 Mar; 170(3):162-76. PubMed ID: 24594364
    [No Abstract]   [Full Text] [Related]  

  • 20. A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors.
    Alessiani M; Petolicchio B; De Sanctis R; Squitieri M; Di Giambattista R; Puma M; Franzese C; Toscano M; Derchi CC; Gilliéron E; Viganò A; Di Piero V
    Eur Neurol; 2022; 85(6):453-459. PubMed ID: 35772386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.